PTHLH and Hypercalcemia: Similarly, PTHrP, which normally acts in a paracrine fashion, can act from the primary tumour to cause a net increase in bone resorption, priming the bone microenvironment to metastasis, while causing tumour-induced hypercalcaemia [73,89].